Literature DB >> 4787755

Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

J R Bianchine, L Sunyapridakul.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4787755     DOI: 10.2165/00003495-197306050-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  107 in total

1.  Treatment of Parkinson's syndrome with L-DOPA on an out-patient basis.

Authors:  C Fehling
Journal:  Z Neurol       Date:  1972

2.  Pigmentation in Parkinson's disease treated with levodopa.

Authors:  K M Grainger
Journal:  Lancet       Date:  1973-01-13       Impact factor: 79.321

3.  Extrapigmentary effects of melanocyte-stimulating hormone in amenorrhoeic women.

Authors:  A J Kastin; S Kullander; N E Borglin; B Dahlberg; K Dyster-Aas; C E Krakau; D H Ingvar; M C Miller; C Y Bowers; A V Schally
Journal:  Lancet       Date:  1968-05-11       Impact factor: 79.321

4.  Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.

Authors:  R S Schwab; A C England
Journal:  Trans Am Neurol Assoc       Date:  1969

5.  Review of 12 months' treatment with L-dopa in Parkinson's disease, with remarks on unusual side effects.

Authors:  J Wodak; B S Gilligan; J L Veale; B J Dowty
Journal:  Med J Aust       Date:  1972-12-02       Impact factor: 7.738

6.  Blood levels of FSH, LH, TSH, and GH in parkinsonian patients before and during L-dopa treatment.

Authors:  P O Lundberg
Journal:  Acta Neurol Scand       Date:  1972       Impact factor: 3.209

7.  Dopa and 3-O-methyldopa in cerebrospinal fluid of Parkinsonism patients during treatment with oral L-dopa.

Authors:  N S Sharpless; D S McCann
Journal:  Clin Chim Acta       Date:  1971-01       Impact factor: 3.786

8.  The effect of L-dopa on monoamine metabolites in Parkinson's disease.

Authors:  M H van Woert; M B Bowers
Journal:  Experientia       Date:  1970

9.  Parkinsoism anDopa.

Authors:  G C Cotzias
Journal:  J Chronic Dis       Date:  1969-11

10.  Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide.

Authors:  N P Plotnikoff; A J Kastin; M S Anderson; A V Schally
Journal:  Neuroendocrinology       Date:  1973       Impact factor: 4.914

View more
  4 in total

1.  Hypertensive crisis in a patient given sinemet, metoclopramide, and amitriptyline.

Authors:  D S Rampton
Journal:  Br Med J       Date:  1977-09-03

Review 2.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 3.  Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?

Authors:  Matthew J Barrett; Lana Sargent; Huma Nawaz; Daniel Weintraub; Elvin T Price; Allison W Willis
Journal:  Mov Disord Clin Pract       Date:  2021-10-08

4.  Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

Authors:  A Dalvi; B Ford
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.